Improve Preparations And Enable Stable Delivery Of Biopharmaceuticals
There is a growing demand for biologics owing to clinical success, favorable safety data, and the ability of biologics to target the underlying causes of disease. Advances in proteins, peptides, nucleic acids, vaccines, and monoclonal antibodies (mAbs) have enabled rapid development of biopharmaceuticals, especially in recent years. According to an article in Molecules, 25 percent […]
Improve Preparations And Enable Stable Delivery Of Biopharmaceuticals Read More »